Clinical trials
Completed Multiple Sclerosis, Chronic Progressive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 12 |
| 2016 | 6 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 120 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Johns Hopkins University | 5 |
| Rigshospitalet, Denmark | 4 |
| Bayer | 3 |
| Genzyme, a Sanofi Company | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Novartis | 3 |
| State University of New York at Buffalo | 3 |
| University College, London | 3 |
| AB Science | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 120 |
| Multiple Sclerosis | 60 |
| Multiple Sclerosis, Relapsing-Remitting | 35 |
| Autoimmune Diseases | 5 |
| Demyelinating Diseases | 5 |
| Fatigue | 5 |
| Nervous System Diseases | 5 |
| Autoimmune Diseases of the Nervous System | 2 |
| Cognitive Dysfunction | 2 |
| Disease Progression | 2 |
Trials
Showing 26 to 50 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.